Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

72.29USD
17 Apr 2014
Price Change (% chg)

$-0.89 (-1.22%)
Prev Close
$73.18
Open
$73.28
Day's High
$73.50
Day's Low
$72.10
Volume
2,348,873
Avg. Vol
1,913,648
52-wk High
$79.37
52-wk Low
$54.90

ESRX.OQ

Chart for ESRX.OQ

About

Express Scripts Holding Company provides healthcare management and administration services on behalf of its clients, which include health maintenance organizations (HMOs), health insurers, third-party administrators, employers, union-sponsored benefit plans, workers compensation plans, and government health programs. The Company... (more)

Overall

Beta: 1.07
Market Cap (Mil.): $56,061.79
Shares Outstanding (Mil.): 775.51
Dividend: --
Yield (%): --

Financials

  ESRX.OQ Industry Sector
P/E (TTM): 31.11 16.72 34.34
EPS (TTM): 2.32 -- --
ROI: 4.51 9.70 75.27
ROE: 8.39 11.13 84.74
Search Stocks

Express Scripts sees long-term earnings growth of up to 20 percent

- Pharmacy benefit manager Express Scripts Holding Co on Thursday forecast 2014 earnings in line with Wall Street expectations and said it sees long-term earnings growth of up to 20 percent per year.

20 Feb 2014

UPDATE 1-Express Scripts sees long-term earnings growth of up to 20 pct

Feb 20 - Pharmacy benefit manager Express Scripts Holding Co on Thursday forecast 2014 earnings in line with Wall Street expectations and said it sees long-term earnings growth of up to 20 percent per year.

20 Feb 2014

Express Scripts profit, outlook match Street estimates

Feb 20 - Pharmacy benefit manager Express Scripts Holding Co on Thursday reported fourth-quarter profit and issued a 2014 earnings forecast in line with Wall Street expectations.

20 Feb 2014

Denmark's Novo Nordisk sees copycat drugs hitting sales

COPENHAGEN - Novo Nordisk, the world's largest insulin producer, raised its 2014 outlook by less than investors had hoped for saying it expected sales to be hit by contract losses in the United States and competition from cheaper generic drugs.

30 Jan 2014

UPDATE 2-Denmark's Novo Nordisk sees copycat drugs hitting sales

* Q4 profit 7.35 mln crowns vs 7.73 bln forecast (Adds comments from CEO, CFO and analysts, details, background, share price)

30 Jan 2014

UPDATE 2-CVS expects 2014 sales gain despite Obamacare

NEW YORK, Dec 18 - CVS Caremark Corp said on Wednesday that it expected sales and earnings to rise in 2014 despite only a "modest" benefit next year from the launch of Obamacare and a ban preventing it from marketing to some Medicare patients.

18 Dec 2013

REFILE-UPDATE 1-Express Scripts quarterly net profit rises; shares dip

Oct 24 - Pharmacy benefit manager Express Scripts Holding Co on Thursday reported higher net earnings for the third quarter but said claims volume declined 9 percent.

25 Oct 2013

Express Scripts quarterly net profit rises, shares dip

- Pharmacy benefit manager Express Scripts Holding Co on Thursday reported higher net earnings for the third quarter but said claims volume declined 9 percent.

24 Oct 2013

Express Scripts 3rd quarter profit rises, shares dip

Oct 24 - Pharmacy benefit manager Express Scripts Holding Co on Thursday reported higher net earnings for the third quarter, but said claims volume declined 9 percent.

24 Oct 2013

SPECIAL REPORT-Economy-class activist investor crashes the corporate party

LOS ANGELES, Oct 23 - Shareholder activists come in different flavors. One is the deep-pocketed investor, such as Carl Icahn or Dan Loeb, who takes big stakes in companies and forces management to change strategy. Another type is the persistent provocateur who buys a handful of shares and agitates on a shoestring. That's John Chevedden.

23 Oct 2013

Competitors

  Price Change
UnitedHealth Group Inc. (UNH.N) $75.78 -2.41
Aetna Inc (AET.N) $67.77 -2.10
CIGNA Corporation (CI.N) $75.64 -1.14

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks